NBIX

NASDAQ · Biotechnology

Neurocrine Biosciences Inc

Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks

$139.49

-2.76 (-1.94%)

As of Sep 23, 9:45 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Very High

Coverage

Buy 31 86%

Hold 5 14%

Sell 0 0%

Price Target

Analyst Price Target -9.0% upside

Low Target $104.30

Average Target $126.93

High Target $177.55

Current Price $139.49

Current
$139.49

Target
$126.93

$104.30 $126.93 avg $177.55

Scenario Analysis

Bear Case

$104.30

-25.2%

Low target

Base Case

$126.93

-9.0%

Avg target

Bull Case

$177.55

+27.3%

High target

Risk/Reward

1.1x

Balanced

Price in Context

52-Week High

$186.12

-25.1% from high

52-Week Low

$122.14

+14.2% from low

50-Day SMA

$139.44

+0.0% vs SMA

200-Day SMA

$135.94

+2.6% vs SMA

RSI (14)

38.6

Neutral

Target vs 52W High

$126.93

-31.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.8%
AMGN Amgen Inc	Hold	43	47%	$190.87	-53.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+139.6%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-15.1%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.4%
MRNA Moderna Inc	Hold	30	37%	$149.45	-17.9%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-63.4%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-40.2%